Momentum Is Strong For Transmedics Group Inc (NASDAQ: TMDX)

After Hours

There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Earlier, Yahoo Finance discussed this stock as it revealed TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4).

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Stocks Info

This NASDAQ-listed company operates within the Medical Devices industry segment, falling under the Healthcare sector. The current market capitalization of Transmedics Group Inc is $2.40B. A total of 0.5 million shares were traded on the day, compared to an average of 630.53K shares.

In the most recent transaction, Gordon Stephen sold 1,903 shares of TMDX for 87.63 per share on Mar 08 ’24. After the transaction, the Chief Financial Officer now owns 23,299 company shares. In a previous transaction on Mar 08 ’24, Khayal Tamer I sold 1,417 shares at 87.80 per share. TMDX shares that Chief Commercial Officer owns now total 25,185.

Among the insiders who sold shares, Gordon Stephen disposed of 15,000 shares on Mar 04 ’24 at a per-share price of $82.80. This resulted in the Chief Financial Officer holding 25,202 shares of TMDX after the transaction. In another insider transaction, TOBIN JAMES R sold 13,380 shares at $83.63 per share on Mar 01 ’24. Company shares held by the Director now total 220,211.

Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. In terms of 52-week highs and lows, TMDX has a high of $99.63 and a low of $36.42.

As of this writing, TMDX has an earnings estimate of -$0.08 per share for the current quarter. EPS was calculated based on a consensus of 4 estimates, with a high estimate of $0.11 per share and a lower estimate of -$0.33. The company reported an EPS of -$0.78 in the last quarter, which was -387.50% lower than expectations of -$0.16.

Balance Sheet Annually/Quarterly

In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. TMDX’s latest balance sheet shows that the firm has $92.45M in Cash & Short Term Investments as of fiscal 2021. There were $43.80M in debt and $23.24M in liabilities at the time. Its Book Value Per Share was $4.20, while its Total Shareholder’s Equity was $67.85M.

Analysts Opinion

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for TMDX is Buy with a score of 4.71.

Most Popular

Related Posts